89 related articles for article (PubMed ID: 15232580)
1. Lymphomagenesis and female-specific lethality in p53-deficient mice occur independently of E2f1.
Wloga EH; Criniti V; Yamasaki L; Bronson RT
Nat Cell Biol; 2004 Jul; 6(7):565-7; author reply 567-8. PubMed ID: 15232580
[No Abstract] [Full Text] [Related]
2. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice.
Wikonkal NM; Remenyik E; Knezevic D; Zhang W; Liu M; Zhao H; Berton TR; Johnson DG; Brash DE
Nat Cell Biol; 2003 Jul; 5(7):655-60. PubMed ID: 12833065
[TBL] [Abstract][Full Text] [Related]
3. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
[TBL] [Abstract][Full Text] [Related]
5. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
6. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
[TBL] [Abstract][Full Text] [Related]
7. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice.
Iglesias A; Murga M; Laresgoiti U; Skoudy A; Bernales I; Fullaondo A; Moreno B; Lloreta J; Field SJ; Real FX; Zubiaga AM
J Clin Invest; 2004 May; 113(10):1398-407. PubMed ID: 15146237
[TBL] [Abstract][Full Text] [Related]
8. Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS.
Agger K; Santoni-Rugiu E; Holmberg C; Karlström O; Helin K
Oncogene; 2005 Jan; 24(5):780-9. PubMed ID: 15531911
[TBL] [Abstract][Full Text] [Related]
9. MIF loss impairs Myc-induced lymphomagenesis.
Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
[TBL] [Abstract][Full Text] [Related]
10. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
Hershko T; Chaussepied M; Oren M; Ginsberg D
Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
[TBL] [Abstract][Full Text] [Related]
11. Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.
Bouwman P; Drost R; Klijn C; Pieterse M; van der Gulden H; Song JY; Szuhai K; Jonkers J
J Pathol; 2011 May; 224(1):10-21. PubMed ID: 21404276
[TBL] [Abstract][Full Text] [Related]
12. Genetic interactions between the Wilms' tumor 1 gene and the p53 gene.
Menke AL; Clarke AR; Leitch A; Ijpenberg A; Williamson KA; Spraggon L; Harrison DJ; Hastie ND
Cancer Res; 2002 Nov; 62(22):6615-20. PubMed ID: 12438257
[TBL] [Abstract][Full Text] [Related]
13. Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.
Haines BB; Ryu CJ; Chang S; Protopopov A; Luch A; Kang YH; Draganov DD; Fragoso MF; Paik SG; Hong HJ; DePinho RA; Chen J
Cancer Cell; 2006 Feb; 9(2):109-20. PubMed ID: 16473278
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.
Chen W; Cooper TK; Zahnow CA; Overholtzer M; Zhao Z; Ladanyi M; Karp JE; Gokgoz N; Wunder JS; Andrulis IL; Levine AJ; Mankowski JL; Baylin SB
Cancer Cell; 2004 Oct; 6(4):387-98. PubMed ID: 15488761
[TBL] [Abstract][Full Text] [Related]
15. A novel mitochondrial protein DIP mediates E2F1-induced apoptosis independently of p53.
Stanelle J; Tu-Rapp H; Pützer BM
Cell Death Differ; 2005 Apr; 12(4):347-57. PubMed ID: 15565177
[TBL] [Abstract][Full Text] [Related]
16. The associated contributions of p53 and the DNA mismatch repair protein Msh6 to spontaneous tumorigenesis.
Young LC; Keuling AM; Lai R; Nation PN; Tron VA; Andrew SE
Carcinogenesis; 2007 Oct; 28(10):2131-8. PubMed ID: 17615258
[TBL] [Abstract][Full Text] [Related]
17. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
18. Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation.
Berton TR; Mitchell DL; Guo R; Johnson DG
Oncogene; 2005 Apr; 24(15):2449-60. PubMed ID: 15735727
[TBL] [Abstract][Full Text] [Related]
19. Role of gene E2f1 in susceptibility to bacterial adherence of oral streptococci to tooth surfaces in mice.
Matsumoto N; Salam MA; Watanabe H; Amagasa T; Senpuku H
Oral Microbiol Immunol; 2004 Aug; 19(4):270-6. PubMed ID: 15209999
[TBL] [Abstract][Full Text] [Related]
20. Functional interplay of p53 and Mus81 in DNA damage responses and cancer.
Pamidi A; Cardoso R; Hakem A; Matysiak-Zablocki E; Poonepalli A; Tamblyn L; Perez-Ordonez B; Hande MP; Sanchez O; Hakem R
Cancer Res; 2007 Sep; 67(18):8527-35. PubMed ID: 17875692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
